Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

The multikinase inhibitors Sunitinib and Sorafenib not only inhibit angiogenesis and tumor growth, but also have the potential of interacting with the function of the immune system.

Bibliographic Details
Main Authors:	Porta, Camillo, Paglino, Chiara, Imarisio, Ilaria, Ganini, Carlo, Pedrazzoli, Paolo
Format:	Online
Language:	English
Published:	Ivyspring International Publisher 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119398/

id	pubmed-3119398
recordtype	oai_dc
spelling	pubmed-31193982011-06-28 Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies? Porta, Camillo Paglino, Chiara Imarisio, Ilaria Ganini, Carlo Pedrazzoli, Paolo Review The multikinase inhibitors Sunitinib and Sorafenib not only inhibit angiogenesis and tumor growth, but also have the potential of interacting with the function of the immune system. Ivyspring International Publisher 2011-06-02 /pmc/articles/PMC3119398/ /pubmed/21716852 Text en © Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited.
repository_type	Open Access Journal
institution_category	Foreign Institution
institution	US National Center for Biotechnology Information
building	NCBI PubMed
collection	Online Access
language	English
format	Online
author	Porta, Camillo Paglino, Chiara Imarisio, Ilaria Ganini, Carlo Pedrazzoli, Paolo
spellingShingle	Porta, Camillo Paglino, Chiara Imarisio, Ilaria Ganini, Carlo Pedrazzoli, Paolo Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
author_facet	Porta, Camillo Paglino, Chiara Imarisio, Ilaria Ganini, Carlo Pedrazzoli, Paolo
author_sort	Porta, Camillo
title	Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
title_short	Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
title_full	Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
title_fullStr	Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
title_full_unstemmed	Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?
title_sort	immunological effects of multikinase inhibitors for kidney cancer: a clue for integration with cellular therapies?
description	The multikinase inhibitors Sunitinib and Sorafenib not only inhibit angiogenesis and tumor growth, but also have the potential of interacting with the function of the immune system.
publisher	Ivyspring International Publisher
publishDate	2011
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119398/
_version_	1611461038378582016

Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Similar Items